Sandra J. Lewis Mid-Career Women’s Leadership Institute – American College of Cardiology
Mid-career women are invited to empower the next phase of their professional lives with the Sandra J. Lewis Mid-Career Women’s Leadership Institute.
Related Articles
Fellow in Training to Fellow – American College of Cardiology
Fellowship is the ultimate recognition of professional achievement in cardiology. Signal to peers and patients your commitment to the highest standards of cardiovascular care through…
Eagle’s Eye View: SUMMIT: A Look Into BMI, Adiposity, Tirzepitide and HFpFF – American College of Cardiology
In this week’s View, Dr. Eagle looks at the SUMMIT trial and considers how body mass index (BMI) and central adiposity affect tirzepatide outcomes for…
Cardio-Obstetrics Essentials: Team-Based Management of Cardiovascular Disease and Pregnancy – American College of Cardiology
Meeting Type: Live Meetings Location: Virtually and Heart House, Washington, DC Join card io-obstetrics experts, including Course Chair Natalie Bello, MD, MPH, FACC and Course…
Physical Activity Declines Over Time, Persists After CVD Diagnosis – American College of Cardiology
Adults experience steep declines in moderate to vigorous-intensity physical activity (MVPA) before developing cardiovascular disease, with exercise reduction persisting after diagnosis, according to a cohort…
Wellness and Humanity in the CICU: Part 2: The Provider Perspective – American College of Cardiology
Join ACC’s Critical Care Cardiology Member Section in collaboration with the Society of Critical Care Cardiology for the Wellness and Humanity in the CICU webinar…
How Many Steps a Day to Reduce CVD and CV Death? – American College of Cardiology
New research shows that just 7,000 steps a day is associated with clinically meaningful improvements in health outcomes, including reductions in cardiovascular disease incidence and…
SOGALDI-PEF: Dapagliflozin Plus Spironolactone More Effective Than Monotherapy – American College of Cardiology
In patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), the combination of dapagliflozin plus spironolactone led to a greater reduction in…
ACC Anywhere
ACC Anywhere is designed for healthcare professionals involved in delivering cardiovascular care and looking to enhance their knowledge.
What Should I Do About an Elevated Lp(a) Based on Current Evidence and Available Treatments? – American College of Cardiology
High levels of Lp(a) impact approximately 1 in 5 individuals globally, signaling an elevated risk of heart attacks, strokes, and valve disease. How should clinicians…
What Should I Do About an Elevated Lp(a) Based on Current Evidence and Available Treatments? – American College of Cardiology
High levels of Lp(a) impact approximately 1 in 5 individuals globally, signaling an elevated risk of heart attacks, strokes, and valve disease. How should clinicians…